Mean ICA was 48.78 ± 6.51 and topographic ACD was 3.76±0.30 mm in the control group (p
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Aim: To determine whether the biomicroscopic, topographic and biomechanical properties of the anterior segment and the tearfunction have changed in Thalassemia Major (TM) patients.Material and Methods: Eighty-eight eyes of patients with TM and 102 eyes of healthy controls paired with age, gender, and sphericalequivalent were included in this cross- sectional case-control study.
📊
Temel Bulgular & Veri:Biomicroscopic, topographic and biomechanical findings ofanterior segment and Schirmer test measurements were compared between the two groups.Results: The mean age was found to be 15.11±6.01years in TM group, and 13.83±4.92 years in the control group (p=0.17).
💡
Sonuç & Katkı:Mean ICA was 48.78 ± 6.51 and topographic ACD was 3.76±0.30 mm in the control group (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Aim: To determine whether the biomicroscopic, topographic and biomechanical properties of the anterior segment and the tearfunction have changed in Thalassemia Major (TM) patients.Material and Methods: Eighty-eight eyes of patients with TM and 102 eyes of healthy controls paired with age, gender, and sphericalequivalent were included in this cross- sectional case-control study. Biomicroscopic, topographic and biomechanical findings ofanterior segment and Schirmer test measurements were compared between the two groups.Results: The mean age was found to be 15.11±6.01years in TM group, and 13.83±4.92 years in the control group (p=0.17). In 34(38.63%) patients with TM, minor peripheral lens opacities were detected. Visual acuity was 20/20 in all patients with lens opacity.The mean iridocorneal angle (ICA) was 44.67±5.86 and the topographic anterior chamber depth (ACD) was 3.65±0.28 mm in the TMpatients. Mean ICA was 48.78 ± 6.51 and topographic ACD was 3.76±0.30 mm in the control group (p
🔖
Bu Makaleye Atıf Yap
SAYIN, N., AYDOĞAN, G., ERDOĞAN, M., BAYRAMOĞLU, S. E., EKİNCİ, D. Y. (2022). Anterior segment parameters and tear functions in patients with thalassemia major. Annals of Medical Research, Cilt: 26 - Sayı: 10, 2245–2249. https://ajindex.com/articles/447400
Cao A, Galanello R. Beta-thalassemia. Genet Med. 2010;12:61-76
Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353:1135-46
Thein SL. The molecular basis of beta-thalassemia. Cold Spring Harb Perspect Med 2013;3:011700
Aksoy A, Aslankurt M, Aslan L, et al. Ocular findings in children with thalassemia major in Eastern Mediterranean. Int J Ophthalmol 2014;7:118-21
Bueno-Gimeno I, Gene-Sampedro A, Pinero-Llorens DP, et al. Corneal biomechanics, retinal nerve fiber layer, and optic disc in children. Optom Vis Sci 2014;91:1474-82
Giardina P, Schneider R, Lesser M, et al. Abnormal bone metabolism in thalassemia. Endocrine Disorders in Thalassemia: Springer 1995.39-46
Jensen CE, Tuck SM, Agnew JE, et al. High prevalence of low bone mass in thalassaemia major. Br J Haematol 1998;103:911-5
Shamshirsaz AA, Bekheirnia MR, Kamgar M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord 2003;3:4
Nowroozzadeh MH, Kalantari Z, Namvar K, et al. Ocular refractive and biometric characteristics in patients with thalassaemia major. Clin Exp Optom 2011;94:361-6
Wu CH, Yang CP, Lai CC, et al. Deferoxamine retinopathy: spectral domain-optical coherence tomography findings. BMC Ophthalmol 2014;14:88
Gartaganis SP, Georgakopoulos CD, Exarchou A, et al. Alterations in conjunctival cytology and tear film dysfunction in patients with beta-thalassemia. Cornea 2003;22:591-7
Taneja R, Malik P, Sharma M, et al. Multiple transfused thalassemia major: ocular manifestations in a hospitalbased population. Indian J Ophthalmol 2010;58:125-30
Ghugre NR, Enriquez CM, Gonzalez I, et al. MRI detects myocardial iron in the human heart. Magn Reson Med 2006;56:681-6
Anderson L, Holden S, Davis B, et al. Cardiovascular T2- star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-9
Hankins JS, McCarville MB, Loeffler RB, et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood 2009;113:4853-5
Wood JC, Kang BP, Thompson A, et al. The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores. Blood 2010;116:537-43
Livrea M, Tesoriere L, Pintaudi A, et al. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996;88:3608-14